Meibomian gland morphology and tear osmolarity

Changes with accutane therapy

William Mathers, W. J. Shields, M. S. Sachdev, W. M. Petroll, J. V. Jester

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p <0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p <0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p <0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.

Original languageEnglish (US)
Pages (from-to)286-290
Number of pages5
JournalCornea
Volume10
Issue number4
StatePublished - 1991
Externally publishedYes

Fingerprint

Meibomian Glands
Isotretinoin
Tears
Osmolar Concentration
Blepharitis
Therapeutics
Rose Bengal
Staining and Labeling

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Mathers, W., Shields, W. J., Sachdev, M. S., Petroll, W. M., & Jester, J. V. (1991). Meibomian gland morphology and tear osmolarity: Changes with accutane therapy. Cornea, 10(4), 286-290.

Meibomian gland morphology and tear osmolarity : Changes with accutane therapy. / Mathers, William; Shields, W. J.; Sachdev, M. S.; Petroll, W. M.; Jester, J. V.

In: Cornea, Vol. 10, No. 4, 1991, p. 286-290.

Research output: Contribution to journalArticle

Mathers, W, Shields, WJ, Sachdev, MS, Petroll, WM & Jester, JV 1991, 'Meibomian gland morphology and tear osmolarity: Changes with accutane therapy', Cornea, vol. 10, no. 4, pp. 286-290.
Mathers W, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland morphology and tear osmolarity: Changes with accutane therapy. Cornea. 1991;10(4):286-290.
Mathers, William ; Shields, W. J. ; Sachdev, M. S. ; Petroll, W. M. ; Jester, J. V. / Meibomian gland morphology and tear osmolarity : Changes with accutane therapy. In: Cornea. 1991 ; Vol. 10, No. 4. pp. 286-290.
@article{2315fa9f94ce477d9ab181d84b0131c1,
title = "Meibomian gland morphology and tear osmolarity: Changes with accutane therapy",
abstract = "We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p <0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p <0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p <0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.",
author = "William Mathers and Shields, {W. J.} and Sachdev, {M. S.} and Petroll, {W. M.} and Jester, {J. V.}",
year = "1991",
language = "English (US)",
volume = "10",
pages = "286--290",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Meibomian gland morphology and tear osmolarity

T2 - Changes with accutane therapy

AU - Mathers, William

AU - Shields, W. J.

AU - Sachdev, M. S.

AU - Petroll, W. M.

AU - Jester, J. V.

PY - 1991

Y1 - 1991

N2 - We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p <0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p <0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p <0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.

AB - We evaluated the meibomian gland function of 11 patients before and during treatment with isotretinoin (Accutane) by assessing tear osmolarity, meibomian gland morphology, tear production, rose bengal staining, and meibomian gland excreta. We found, during Accutane use, that atrophic by meibography. Excreta thickness increased from 1.7 ± 0.9 to 3.1 ± 1.2 (p <0.005), and expressible excreta volume decreased from 1.52 ± 0.68 to 1.10 ± 0.3 (p <0.05) (scale 1-4). We also found a significant increase in tear osmolarity from 304.9 ± 11 to 316.3 ± 10 mosmol/L (p <0.005). There was no significant change in the Schirmer test during treatment. We suggest that the clinical symptoms of blepharitis during Accutane therapy are related to decreased meibomian gland function and consequent increased tear evaporation and tear osmolarity.

UR - http://www.scopus.com/inward/record.url?scp=0026327205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026327205&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 286

EP - 290

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 4

ER -